Deep Track Capital, LP 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:44 am Sale | 2024-09-30 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deep Track Capital, LP | 1,000,000 1.970% | -1,184,440 (-54.22%) | Filing |
| 2024-02-14 08:56 am Purchase | 2023-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deep Track Capital, LP | 2,184,440 6.030% | 1,894,118 (+652.42%) | Filing |
| 2023-06-30 4:00 pm Purchase | 2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deep Track Capital, LP | 290,322 9.990% | 290,322 (New Position) | Filing |